European Luxury Stocks Get Lift After LVMH Update Soothes Concerns
By Helena Smolak
European luxury shares gained after LVMH's better-than-expected first-quarter sales eased investors' concerns, setting a positive tone for the sector amid subdued consumer sentiment.
At 0830 GMT, LVMH shares were 3.9% higher at EUR812.50, and have risen 9.5% year to date. The Stoxx Europe luxury index was 1.3% higher, outperforming most European blue-chip indexes, with Hermes, Richemont, and Burberry all trading up more than 1%.
French luxury conglomerate LVMH--which counts Dior and Louis Vuitton among its brands--said late Tuesday that revenue for the first three months of the year fell 2% to 20.69 billion euros (21.97 billion), roughly in line with analysts who had expected a sluggish start to the year.
LVMH's sales results weren't as weak as the market had feared, and should be taken positively, considering the muted investor sentiment that prevailed ahead of the update, Barclays analysts Carole Madjo and Wendy Liu said in a note.
LVMH is the first of Europe's main luxury companies to report first-quarter data.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
April 17, 2024 05:04 ET (09:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track